228 related articles for article (PubMed ID: 19338137)
1. Effects of alpha-lipoic acid administration on plasma glucose levels, total malondialdehyde values and withdrawal signs in rats treated with morphine or morphine plus naloxone.
Pinelli A; Cighetti G; Trivulzio S
Arzneimittelforschung; 2009; 59(2):72-8. PubMed ID: 19338137
[TBL] [Abstract][Full Text] [Related]
2. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
Pinelli A; Cighetti G; Trivulzio S
Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
[TBL] [Abstract][Full Text] [Related]
3. Morphine or its withdrawal affects plasma malondialdehyde, vitamin E levels and absence or presence of abstinence signs in rats.
Pinelli A; Cighetti G; Trivulzio S; Accinni R
J Pharm Pharmacol; 2009 Apr; 61(4):487-91. PubMed ID: 19298696
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine.
Pinelli A; Trivulzio S
J Pharmacol Toxicol Methods; 1997 Nov; 38(3):117-31. PubMed ID: 9523765
[TBL] [Abstract][Full Text] [Related]
5. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
Sobor M; Timár J; Riba P; Friedmann T; Király KP; Gyarmati S; Al-Khrasani M; Fürst S
Brain Res Bull; 2011 Jan; 84(1):53-60. PubMed ID: 20934489
[TBL] [Abstract][Full Text] [Related]
6. Quantitative opioid withdrawal signs in rats: effects exerted by clothiapine administration.
Pinelli A; Trivulzio S; Ciapponi PM
Fundam Clin Pharmacol; 1997; 11(4):346-55. PubMed ID: 9263765
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
8. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
[TBL] [Abstract][Full Text] [Related]
9. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of morphine withdrawal signs by low level laser therapy in rats.
Mirzaii-Dizgah I; Ojaghi R; Sadeghipour HR; Karimian SM; Sohanaki H
Behav Brain Res; 2009 Jan; 196(2):268-70. PubMed ID: 18926854
[TBL] [Abstract][Full Text] [Related]
11. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
12. The roles of melatonin and vitamin E plus selenium in prevention of oxidative stress induced by naloxone-precipitated withdrawal in heroin-addicted rats.
Cemek M; Büyükokuroğlu ME; Hazman O; Konuk M; Bulut S; Birdane YO
Biol Trace Elem Res; 2011 Jul; 142(1):55-66. PubMed ID: 20544301
[TBL] [Abstract][Full Text] [Related]
13. Effects of tizanidine administration on precipitated opioid withdrawal signs in rats.
Pinelli A; Trivulzio S; Spezia R
Drug Alcohol Depend; 1998 Mar; 50(1):81-8. PubMed ID: 9589275
[TBL] [Abstract][Full Text] [Related]
14. Characterization of blood glucose level regulation in mouse opioid withdrawal models.
Park SH; Sim YB; Kang YJ; Kim SM; Lee JK; Jung JS; Suh HW
Neurosci Lett; 2010 Jun; 476(3):119-22. PubMed ID: 20226840
[TBL] [Abstract][Full Text] [Related]
15. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
Fdez Espejo E; Cador M; Stinus L
Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
[TBL] [Abstract][Full Text] [Related]
16. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
17. Effects of ondansetron administration on opioid withdrawal syndrome observed in rats.
Pinelli A; Trivulzio S; Tomasoni L
Eur J Pharmacol; 1997 Dec; 340(2-3):111-9. PubMed ID: 9537805
[TBL] [Abstract][Full Text] [Related]
18. Effects of intragastric agmatine on morphine-induced physiological dependence in beagle dogs and rhesus monkeys.
Su RB; Lu XQ; Huang Y; Liu Y; Gong ZH; Wei XL; Wu N; Li J
Eur J Pharmacol; 2008 Jun; 587(1-3):155-62. PubMed ID: 18455724
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.
Singh P; Sharma B; Gupta S; Sharma BM
Psychopharmacology (Berl); 2015 Jan; 232(2):465-75. PubMed ID: 25059539
[TBL] [Abstract][Full Text] [Related]
20. Alpha-tocopherol and alpha-lipoic acid enhance the erythrocyte antioxidant defence in cyclosporine A-treated rats.
Lexis LA; Fassett RG; Coombes JS
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):68-73. PubMed ID: 16433894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
